Literature DB >> 13446845

Quantitative biochemical differences between tumor and host as a basis for cancer chemotherapy. V. Niacin and 6-aminonicotinamide.

D M SHAPIRO, L S DIETRICH, M E SHILS.   

Abstract

Entities:  

Keywords:  CYTOTOXIC DRUGS; NICOTINIC ACID/antagonists

Mesh:

Substances:

Year:  1957        PMID: 13446845

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  [SPECTROFLUOROMETRIC DETERMINATION OF THEINCORPORATION OF 6-AMINONICOTINAMIDE INTO OXIDATED PYRIDINE NUCLEOTIDE IN THE KIDNEY].

Authors:  H HERKEN; V NEUHOFF
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-05-29

2.  The continuous alternating chemotherapy of cancer.

Authors:  M ARONOVITCH
Journal:  Can Med Assoc J       Date:  1960-08-20       Impact factor: 8.262

3.  Some metabolic and morphological alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide.

Authors:  N Ofori-Nkansah; F von Bruchhausen
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

4.  Metabolic alterations in Yoshida ascites tumour cells caused by 6-aminonicotinamide and prevented by nicotinamide.

Authors:  N Ofori-Nkansah; F von Bruchhausen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  Metabolism of 6-aminonicotinic acid in Escherichia coli.

Authors:  J R Cobb; S C Pearcy; R K Gholson
Journal:  J Bacteriol       Date:  1977-09       Impact factor: 3.490

Review 6.  Emerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma.

Authors:  Marta Anna Kowalik; Amedeo Columbano; Andrea Perra
Journal:  Front Oncol       Date:  2017-05-11       Impact factor: 6.244

7.  Tissue NAD levels and the response to irradiation of cytotoxic drugs.

Authors:  G Calcutt; S M Ting; A V Preece
Journal:  Br J Cancer       Date:  1970-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.